Broker recommendation of high-risk REITs cost retirees their savings
We remember the pitches. Non-traded REITs sold as stable income tools with little downside. Brokers showed charts with 8% distributions and called them conservative. We ...
Read More →
Pfizer dividend faces pressure as pipeline transitions and debt weighs
Pfizer’s stock has become a case study in how quickly a pharmaceutical dividend can move from safe to uncertain. The company trades near multi-year lows ...
Read More →
Unauthorized trading drained elderly investor accounts before anyone noticed
We watched this pattern unfold on Wall Street more times than I care to remember. A broker builds trust with an elderly client. The client ...
Read More →
How broker-dealer failures to supervise enable churning and suitability violations
A wave of recent FINRA disciplinary actions has exposed widespread failures by broker-dealers to supervise their registered representatives. In case after case, firms allowed churning, ...
Read More →
82 Percent of Managers Are Burned Out: What the 2025 Data Means for Companies
The data that got my attention Eighty-two percent of managers say they feel burned out. That is not an anomaly. It is a structural warning. ...
Read More →
Johnson & Johnson maintains dividend growth after Kenvue spinoff
Johnson & Johnson remains one of the most reliable dividend payers in the healthcare sector after spinning off its consumer health business as Kenvue in ...
Read More →
